Capsules per day
8 million
Year of foundation
1998
Formulations developed
500+
Countries on four continents
28+
Production lines
4
Laboratories
3

Quality and Control

capsule shapes

The capsule collection as part of your brand

In the food supplements industry, the soft gelatine capsule is much more than just a carrier for active ingredients — it is part of the brand’s identity and a powerful marketing tool. Its shape, colour and appearance influence perceptions of quality, product positioning and consumer confidence.

export map

Global presence

Phytopharma exports its products to 28 countries in Europe, Asia, North America and Africa, including the UK, Germany, China and the US.

The process

Your idea
  1. Your idea

    Share your vision from the active ingredients to the packaging.

  2. Development

    Our team develops the optimal formula and technological solution for manufacturing your product.

  3. Production

    The manufacturing process is carried out under the full control of our qualified specialists.

  4. Packaging

    We offer an individual approach to the packaging of each product under strictly controlled conditions.

  5. Success

    Your product reaches the market supported by our experience, technological expertise,
    and commitment to excellence.

Certificates

team

About Phytopharma

Phytopharma was founded in 1998 with the mission of developing and manufacturing highly effective food supplements in the form of soft gelatine capsules. The company combines many years of manufacturing experience with state-of-the-art technology and international quality standards.

The management and production facilities are located in the village of Oreshak, Bulgaria, where a fully automated complex ensures efficient and reliable production.

The production system complies with Good Manufacturing Practice (GMP) requirements and is complemented by a rigorous HACCP system, which ensures continuous quality control at every stage. From the very outset, the company has excluded raw materials derived from genetically modified organisms.

The Family Behind Phytopharma

Behind Phytopharma's sustainable growth and success is a team of experienced professionals who lead the company with a clear vision, strong responsibility, and a long-term strategy.

"We look to the future with our hearts and are ready to change the world for the better."

  • Milko Vachev

    CEO

    With many years of experience in manufacturing and management, Milko Vachev is a key figure in the establishment and development of the company. His strategic approach and strong focus on quality have laid the solid foundations of Phytopharma as a reliable manufacturing partner. Under his leadership, the company follows the principles of transparency, sustainable development, and high manufacturing standards.

  • Ivan Vachev

    Sales and Business Development Director

    His role includes all activities outside R&D and production – business development, entering new markets, and expanding existing partnerships. Ivan Vachev is responsible for the strategic positioning of the company and the development of long-term partnerships. Under his leadership, Phytopharma has built a network of partners in more than 30 countries across Europe, Asia, North America, and Africa, and the company continues to actively expand its presence in new markets.

  • Mila Vacheva

    Production Director

    Mila Vacheva is the Production Director at Phytopharma, with a strong scientific background and international experience. She holds a degree in Pharmaceutical Science from the University of Salford and a Master’s degree in Pharmacognosy from University College London. Her professional career began in the R&D department of GlaxoSmithKline in the United Kingdom, where she worked on the development of pharmaceutical inhalation dosage forms. Since joining the company in 2014, she has been responsible for product development, production management, implementation of new technologies, and quality control, contributing to the development of over 200 formulations for international partners.

Send an enquiry


*MOQ 300 000 softgels or blockers


Or type directly